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Copyright © 2008 JCBN Summary In most clinical laboratories, low density lipoprotein (LDL) cholesterol is usually
estimated indirectly with the Friedewald equation or directly with the N-geneous assay. We
assessed LDL-cholesterol values obtained by both methods to find an appropriate fasting
period and to assess the influence of the energy content of the last meal. Blood samples were
taken from 28 healthy volunteers who had consumed a standard meal (107 g of carbohydrate,
658 kcal) followed by a fasting period of 12 and 18 h, or a high-energy meal (190 g of
carbohydrate, 1011 kcal) with a fasting period of 12 h. Prolongation of the fasting period from
12 h to 18 h decreased glucose level, but did not decrease triacylglycerol, total cholesterol, or
high density lipoprotein (HDL) cholesterol. LDL-cholesterol levels measured with the N-
geneous assay did not change (94.0 ± 21.5 to 96.3 ± 19.1 mg/dl). LDL-cholesterol levels
calculated with the Friedewald equation were also similar after fasting periods of 12 h
(98.5 ± 21.4 mg/dl) and 18 h (99.7 ± 20.2 mg/dl). The high-energy meal did not change the level
of LDL-cholesterol measured with the N-geneous assay (96.1 ± 21.2 mg/dl), or the glucose,
triacylglycerol, total cholesterol, or HDL-cholesterol level, but LDL-cholesterol levels evaluated
from the Friedewald equation (92.6 ± 20.3 mg/dl) became significantly lower. A fasting time
longer than 12 h is not necessary to obtain reasonable blood lipid levels. The Friedewald
equation gave higher LDL-cholesterol levels than N-geneous assay in young Japanese females
who had eaten a low-energy meal, and lower values when they had eaten a high-energy meal.
Thus, it may be necessary to pay attention to energy of nigh meal prior to blood withdrawal.
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Introduction
A high level of low density lipoprotein cholesterol (LDL-
cholesterol) is a major risk factor for the development of
coronary heart disease [1–5]. LDL-cholesterol level has
been estimated indirectly from measurements of total
cholesterol, triacylglycerol, and high density lipoprotein
cholesterol (HDL-cholesterol) by means of the Friedewald
equation [6] in most clinical laboratories.N. Fukuyama et al.
J. Clin. Biochem. Nutr.
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[LDL-cholesterol] = [total cholesterol] −
[HDL-cholesterol] − [triacylglycerol]/5
The Friedewald equation was verified by comparing its
results with those of a reference method known as beta-
quantification, in which total LDL mass is directly measured
by analytical ultracentrifugation [7,  8]. LDL-cholesterol
concentration derived by use of the Friedewald equation is
invalid when samples are collected in the non-fasting state
or in the presence of increased triacylglycerol levels [8, 9].
The beta-quantification method requires complicated instru-
mentation including ultracentrifugation and polyanion-
precipitation steps, and is not available for routine use in
most laboratories. However, a new and relatively simple
analytical method called N-geneous LDL-cholesterol assay
was developed in 1998 by Rifai et al. [10–12]. The results
obtained with this method correlated highly with those of
beta-quantification assay, and met the established analytical
performance goals recommended by the National Cholesterol
Education Program (NCEP) [13]. Furthermore, LDL-
cholesterol values obtained with the N-geneous assay are
not affected by the presence of increased levels of triacyl-
glycerol, unlike the Friedewald equation.
Since the Friedewald equation has still considerable
advantages including simplicity and lack of cost, it seemed
worthwhile to perform a detailed validation study of the
Friedewald equation utilizing data obtained with the N-
geneous assay as reference values. The influence of restric-
tions to the Friedewald equation, i.e., that blood should be
sampled in the fasted state and that the triacylglycerol level
should not be high, is also an important consideration. It still
needs to be established clearly how long patients should fast
before blood is drawn, and whether or not the energy content
of the last meal influences the LDL-cholesterol value even
though the blood is drawn in the fasted state.
Thus, we assessed values obtained with the Friedewald
equation by comparing them with the levels obtained by use
of the N-geneous assay, in order to determine an appropriate
fasting period and to uncover the influence of the energy
content of the last meal.
Methods
Subjects
Twenty-eight healthy Japanese female volunteers (20–23
years old) were recruited for this study. The body mass index
(BMI) of the subjects was 20.4 ± 1.7 kg/m2. None was obese
(BMI>kg/m2) but there were five lean subjects (BMI =
17.3 − 18.4 kg/m2) in this group. The body fat ratio was
25.4 ± 3.4%, as measured by using the bioimpedance
analysis method (Tanita Body Fat Analyzer, model no. TBF-
210, Tanita Co., Tokyo). This study was approved by The
Human Research Ethics Committee at Tokyo University of
Agriculture, and all participants gave written informed consent.
Blood sampling and clinical analysis
Blood samples were taken from the antecubital vein and
analyzed by Mitsubishi Kagaku Bio-Clinical Laboratories,
Inc., Tokyo. The following parameters were measured:
glucose (Sica Liquid Glu, Kanto Kagaku, Tokyo), triacyl-
glycerol (Determiner-c-Tg, Kyowa Medex, Tokyo), total
cholesterol (Dia Auto T-Cho, Dia Reagents, Tokyo), HDL-
cholesterol (Cholestest HDL, Daiichi Pure Chemicals Co.
Ltd., Tokyo), and LDL-cholesterol (N-geneous assay, Daiichi
Pure Chemicals Co. Ltd., Tokyo), LDL-cholesterol level
was also estimated by using the Friedewald equation [6].
Meals
Two kinds of meals (standard meal and high-energy meal)
were used. The standard meal has an energy content of
658 kcal and contains standard amounts of carbohydrate
(107 g), protein (19 g), and fat (16 g), with 44 mg choles-
terol, based on the 1998 National Nutrient State report,
Japan [14]. The high-energy meal has an energy content of
1,011 kcal; its carbohydrate content was increased to 190 g,
with unchanged levels of protein, fat and cholesterol. We
increased only carbohydrate in the high-energy meal, because
in preliminary trials, volunteers found difficulty to eat a
high-energy meal with an increased fat content, complaining
that it was too greasy. These meals corresponded to a
common Japanese dinner menu, consisting of curry, rice,
miso soup, and dessert.
Protocols
Two kinds of fasting period were examined. In the first
trial (12 h fasting period), the subjects were asked to eat
breakfast and lunch (around noon) as usual. Then all 28
volunteers were gathered in the dining room where meals
were prepared by students majoring in nutritional science,
started to eat together at seven o’clock in the afternoon, and
were asked to fast for the following 12 h. At 8 am next
morning, blood samples were withdrawn in the fasted state.
After one week the second trial (18 h fasting period) was
performed. The same subjects were asked to eat breakfast as
usual around 8 am. Then they were given the standard meal
at 1 pm and asked to fast for 18 h. At 8 am next morning,
blood samples were withdrawn in the same way as in the
first trial. In the third week, the third trial (high-energy
meal) was performed. The same subjects were asked to eat
breakfast and lunch (around noon) as usual. Then at 7 pm
they ate the high-energy meal together in the dining room
and were asked to fast for the following 12 h. At 8 am next
morning, blood samples were withdrawn in the fasted state.
Throughout all experimental periods, they were allowed to
drink tap water or mineral water, even in the fasting periods.
Statistical analysis
All evaluated variables are presented as means ± SD.Validation of the Friedewald Equation
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Statistical analysis was performed with the use of
StatView512 (Ver1.2, BrainPower Inc., CA). Comparisons
between 2 groups were done by paired t test Data were
considered statistically significant at p<0.05.
Results
As shown in Table 1, first and second trials, prolongation
of the fasting period from 12 h to 18 h decreased the glucose
level from 83.6 ± 4.6 to 80.8 ± 6.4 mg/dl (p<0.05 paired t
test). Triacylglycerol, total cholesterol, and HDL-cholesterol
levels did not change. LDL-cholesterol levels measured with
the N-geneous assay did not significantly change (from
94.0 ± 21.5 to 96.3 ± 19.1 mg/dl). LDL-cholesterol levels
calculated by use of the Friedewald equation were also
similar after fasting periods of 12 h (98.5 ± 21.4 mg/dl)
and 18 h (99.7 ± 20.2 mg/dl). The LDL-cholesterol levels
determined by the Friedewald equation were significantly
higher than those by the N-geneous assay after both fasting
periods. This finding is different from most previous results,
which have indicated that the Friedewald equation underesti-
mates LDL-cholesterol level [8, 9, 15].
In the study to examine the influence of the energy
content of the last meal on LDL-cholesterol levels, data
obtained after a 12 h fasting period following the standard
meal and the high-energy meal were compared (the first trial
and the third trial of Table 1). Levels of glucose,
triacylglycerol, total cholesterol, and HDL-cholesterol did
not change. LDL-cholesterol level measured by the N-
geneous assay did not change either (96.1 ± 21.2 vs
94.0 ± 21.5 mg/dl). However, that determined by the
Friedewald equation became significantly lower in the high-
energy meal trial (92.6 ± 20.3 vs 98.5 ± 21.4 mg/dl, p<0.05
paired t test). To examine these changes in detail, individual
values of LDL-cholesterol obtained by the Friedewald
equation and by the N-geneous assay were compared in the
subjects given the standard meal (Fig. 1A) and the high-
energy meal (Fig. 1B). In the case of the standard meal,
LDL-cholesterol levels determined by the Friedewald
equation were higher than the levels determined by the N-
geneous assay in all but two subjects. In contrast, in the case
of the high-energy meal, LDL-cholesterol levels determined
by the Friedewald equation were lower than the levels
determined by the N-geneous assay in all but four subjects.
This indicates that the Friedewald equation underestimates
LDL-cholesterol when the night meal prior to blood with-
drawal is high in energy, but overestimates it when the night
meal is low in energy.
Discussion
High serum cholesterol is a major risk factor for coronary
heart disease [1–5]. Serum cholesterol is distributed mainly
among three major lipoprotein classes: very low density
lipoproteins (VLDL), low density lipoproteins (LDL), and
high density lipoproteins (HDL), with small amounts in
intermediate density lipoproteins (IDL) and lipoproteins (a)
[9, 15]. About 60–70% of cholesterol is contained in LDL.
Thus, it is very important to evaluate LDL-cholesterol
levels, as well as total cholesterol [9, 15–17]. To measure
LDL-cholesterol directly, the LDL fraction in the serum has
to be isolated by ultracentrifugation, followed by measure-
Table 1. Blood glucose and lipids levels in 28 subjects
#p<0.05 vs the 1st trial (paired t test)
*p<0.01 vs LDL-cholesterol levels by N-geneous assay (paired t test)
Trials Meals
Fasting period 
(hours)
Glucose 
(mg/dL)
Triacylglycerol 
(mg/dL)
Total-
cholesterol 
(mg/dL)
HDL-
cholesterol 
(mg/dL)
LDL-cholesterol 
levels by N-
geneous assay 
(mg/dL)
LDL-cholesterol 
levels from the 
Friedewald 
equation 
(mg/dL)
1st Standard meal 12 83.6 ± 4.60 63.6 ± 19.1 172.5 ± 23.5 61.3 ± 12.3 94.0 ± 21.5 98.5 ± 21.4*
2nd Standard meal 18 80.8 ± 6.4# 61.9 ± 23.4 173.8 ± 21.3 61.6 ± 11.7 96.3 ± 19.1 99.7 ± 20.2*
3rd high-energy meal 12 83.7 ± 5.6 65.6 ± 21.9 168.31 ± 22.1 62.7 ± 11.7 96.1 ± 21.2 92.6 ± 20.3*
Fig. 1. Comparison between LDL-cholesterol levels determined
by the N-geneous assay (Direct) and the Friedewald
equation (Indirect) after a 12 h fasting period in 28
subjects. (A) After eating the standard diet (the first
trial). (B) After eating the high-energy meal (the third
trial). Values determined by the two methods in the same
individuals are connected by lines. Large circles and bars
indicate mean values and SD, respectively. *p<0.01
paired t test.N. Fukuyama et al.
J. Clin. Biochem. Nutr.
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ment of the cholesterol content. The process requires
complicated technique and costly instrumentation [8]. In
contrast, the Friedewald method does not require additional
measurement other than total cholesterol, HDL-cholesterol,
and triacylglycerol. In most epidemiological studies and in
the general clinical setting [18, 19], LDL-cholesterol value
is obtained by use of the Friedewald equation. This equation
was validated by Warnick et al. [8], who confirmed that the
equation is valid when the triacylglycerol level is less than
400 mg/dl. More detailed validation studies have not been
performed because the beta-quantification method is not
available in routine clinical settings. However, even in
countries where people used not to favor lipid-rich foods,
dietary habits are rapidly becoming Westernized, and the
morbidity rate of coronary heart disease is increasing [20].
Consequently, the use of the Friedewald equation is becoming
even more widespread, because of its simplicity and lack of
cost. Since the N-geneous assay is more convenient than the
beta-quantification method, we employed it to investigate
two undefined issues regarding the Friedewald equation.
The first of these was the appropriate fasting period. We
found that the values after 18 h of fasting were not
significantly different from those after 12 h (Table 1).
Therefore, 12 h is a sufficient fasting period. Consumption
of a high energy meal prior to fasting did not change the
mean value of LDL-cholesterol determined by N-geneous
assay compared with the control diet, but it significantly
reduced the LDL-cholesterol level obtained by use of the
Friedewald equation (Table 1). This is consistent with
reported findings that the Friedewald method under-
estimates LDL-cholesterol [13, 15]. Even at low cholesterol
levels, underestimation of LDL-cholesterol occurs [21].
Thus, the overestimation of LDL-cholesterol level by the
Friedewald equation in the standard meal trial was puzzling.
Since triacylglycerol was not significantly affected by the
energy content of the previous meal in this study, the reason
for the increase or decrease in LDL-cholesterol obtained
with the Friedewald equation is obscure. One possible
reason might be the low triacylglycerol levels and young age
of the subjects in this study. Another reason may be that the
Japanese standard energy content meal might have had a
lower energy content than meals given in other countries in
which underestimation of the Friedewald equation was
reported [9, 15, 21]. Further study is needed to see whether
this result is peculiar to Japanese young females or can be
generalized to other groups.
Conclusion
Prolongation of fasting time beyond 12 h is not necessary
for determination of blood lipid levels. The Friedewald
equation gave higher LDL-cholesterol levels than N-geneous
assay in young Japanese females who had eaten a low-
energy meal before fasting, and lower values when they had
eaten a high-energy meal. Thus, it may be necessary to pay
attention to energy of night meal prior to blood withdrawal.
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